In vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitors.

Documenti analoghi

• Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro.
  di: Hayashi, S, et al.
  Pubblicazione: (1990)
• Adenallene and cytallene: acyclic-nucleoside analogues that inhibit replication and cytopathic effect of human immunodeficiency virus in vitro.
  di: Hayashi, S, et al.
  Pubblicazione: (1988)
• Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides.
  di: Dahlberg, J E, et al.
  Pubblicazione: (1987)
• Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins.
  di: Kageyama, S, et al.
  Pubblicazione: (1994)
• Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
  di: Mitsuya, H, et al.
  Pubblicazione: (1986)